Impact of antipyretics on acute asthma exacerbation during respiratory infection-A nationwide population-based study

Background: Antipyretics are frequently used in pediatric practice. Both acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to increase the risk of asthma exacerbation. The study investigated antipyretic use during respiratory infection in children and analyzed the ri...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruei-Sian Chung (Author), Yung-Chieh Huang (Author), Yi-Huei Chen (Author), Lin-Shien Fu (Author), Ching-Heng Lin (Author)
Format: Book
Published: Elsevier, 2020-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8bae0a99ae6a43d09e2d7bf3fb81baf9
042 |a dc 
100 1 0 |a Ruei-Sian Chung  |e author 
700 1 0 |a Yung-Chieh Huang  |e author 
700 1 0 |a Yi-Huei Chen  |e author 
700 1 0 |a Lin-Shien Fu  |e author 
700 1 0 |a Ching-Heng Lin  |e author 
245 0 0 |a Impact of antipyretics on acute asthma exacerbation during respiratory infection-A nationwide population-based study 
260 |b Elsevier,   |c 2020-10-01T00:00:00Z. 
500 |a 1875-9572 
500 |a 10.1016/j.pedneo.2020.03.018 
520 |a Background: Antipyretics are frequently used in pediatric practice. Both acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to increase the risk of asthma exacerbation. The study investigated antipyretic use during respiratory infection in children and analyzed the risk of acetaminophen and NSAID for severe asthma exacerbation (AE) in asthmatic children in Taiwan. Methods: We used the data from the National Health Insurance Research Database in 2005. There were 27,095 pediatric asthmatic patients having at least one respiratory infection episode, and 27,095 age- and sex-matched non-asthmatic children with respiratory infection served as controls. These patients were divided into groups with acetaminophen use, NSAID cyclooxygenase-1 (COX-1) use, and no antipyretic use. The rate of AE occurrence within the first 7 days after respiratory infection diagnosis was compared among the groups. Results: During a single episode of respiratory infection, asthmatic patients used fewer antipyretics than controls (48.51% vs. 55.50%, p < 0.001). No difference was observed in the risk of AE occurrence within 7 days after respiratory infection between antipyretic users and antipyretic nonusers (22/13,144 [0.167%] vs. 12/13,951 [0.086%], p = 0.058). Compared with asthmatic children using acetaminophen, those using no antipyretic and COX-1 have lower risks for AE (OR: 0.26, 95% CI: 0.12-0.54, p < 0.001; and OR: 0.14, 95% CI: 0.03-0.61, p = 0.009). Conclusion: In asthmatic children, the rate of AE after a single respiratory infection episode was around 0.144%. The risk of AE was higher in those who took acetaminophen. 
546 |a EN 
690 |a asthma exacerbation (AE) 
690 |a acetaminophen 
690 |a NSAID COX-1 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Pediatrics and Neonatology, Vol 61, Iss 5, Pp 475-480 (2020) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1875957220300589 
787 0 |n https://doaj.org/toc/1875-9572 
856 4 1 |u https://doaj.org/article/8bae0a99ae6a43d09e2d7bf3fb81baf9  |z Connect to this object online.